Davis Stephen
ACADIA Pharmaceuticals Inc. · CEO
Davis Stephen is listed in filings as CEO at ACADIA Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Aug 20, 2024, including sale activity. Recent filings connect the profile to ACADIA Pharmaceuticals Inc. (ACAD). The current snapshot covers public activity from Aug 20, 2024. Reported amounts are shown as $485.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $485k31.7k shares | SellAug 19, 2024 | $15.28 | $25.60 |